Whilst I am excited about this announcement, there is no explicit mention of a partnership (e.g. supply agreement) with Roche. It just states that they will be combining with Roche's Tecentriq. Similar to their announcement that they will be combining Her-Vaxx with Keytruda, there is no explicit mention of a partnership with Merck USA. We are only aware of the partnerships with Merck Germany, Pfizer, Cellularity and Eureka. I think jarpan's question was fair.
Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-56
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $374.8M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $354.6K | 6.902M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 140045 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 873451 | 21 |
View Market Depth
| Last trade - 11.28am 05/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |